Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Diana Leitner (NPI 1043572613)

Field	Value
Entity Type	Individual
Organization	Diana Leitner
Address	1010 N. Kansas
City	Wichita
State	KS
ZIP	67214
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 11, 2012

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider’s billed Medicare activity is concentrated at a modest practice scale: lifetime Medicare revenue is $2.1M and there is no Medicaid billing on file, so the provider is effectively single‑payer (Medicare) in the available claims data. The absence of any Medicaid codes suggests limited engagement with Medicaid populations or that those services are billed under another provider/group.

Revenue concentration is extreme across a very small set of services: the precomputed top‑3 Medicare codes (J0178, J2777, 67028) account for 86.4% of this provider’s total Medicare revenue. In particular, J0178 alone represents $1.3M of revenue (64.7% of Medicare revenue), signaling heavy dependence on a single high‑value medication code.

The code mix points to a retina/medical ophthalmology operation centered on intravitreal therapy and related office‑based procedures: high volumes and dollars for J0178 (Injection, aflibercept), J2777 (faricimab), and the intravitreal injection procedure 67028 support a practice model focused on anti‑VEGF injections and retinal disease management. Additional support codes such as 92134 (retinal OCT imaging) and 92250 (fundus photography) align with a workflow that emphasizes imaging‑guided diagnosis and follow‑up.

Competitive standing for the dominant drug code is modest on a national scale: J0178 ranks #564 of 3204 providers (82th percentile) and is described as “typical, unremarkable volume for this code,” indicating the provider is not a national volume leader for aflibercept despite it driving most practice revenue. J2777 (faricimab) ranks #967 of 2039 (53th percentile) and is also characterized as typical, while J2778 (ranibizumab) sits lower at the 21th percentile, showing mixed positioning across anti‑VEGF agents.

Two service lines are statistical outliers relative to national peers: 99213 (established office visit) ranks #2989 of 457151 (99th percentile) and is labeled an “extreme outlier, far above typical national volume,” and 92134 (retinal OCT) ranks #625 of 26868 (98th percentile) with the same outlier label. These signals indicate an unusually high volume of established E/M visits and OCT imaging per provider relative to national peers, consistent with frequent follow‑up visits and imaging tied to ongoing injection therapy.

Ancillary coding patterns add nuance: the provider reports 727 claims for J7999 (compounded drug) generating $29.1K and ranking #77 of 1333 providers (94th percentile), which is described as typical but toward the high end for that code. Smaller revenue contributors such as 92250, 67228, and procedure codes for laser or retinal services appear but together make up a small fraction of total Medicare revenue, reinforcing the injection/imaging focus.

Operational and reimbursement sensitivity is a tangible business risk given the heavy reliance on medication and injection services: with J0178 at 64.7% of Medicare revenue and the top three codes at 86.4% overall, any shifts in drug utilization, reimbursement, or prior‑authorization practices for these agents could materially affect practice revenue. The lack of Medicaid billing further concentrates exposure to Medicare policy and payer dynamics.

The provider has an established billing history with an NPI enumeration date of 2012-06-11 (approximately 14 years ago), which supports interpretation of patterns as the output of an experienced, ongoing practice rather than a short‑term anomaly. Lifetime Medicare receipts of $2.1M combined with the long enumeration window indicate a stable mid‑scale Medicare practice focused on retinal injections and associated follow‑up services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,950	$690	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	10,790	$30	$312.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,600	$90	$136.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,340	$60	$76.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,580	$30	$67K
J2778	Injection, ranibizumab, 0.1 mg	320	$180	$57.9K
J7999	Compounded drug, not otherwise classified	730	$40	$29.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	270	$80	$20.4K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	170	$40	$7K
67228	In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space…	20	$240	$4.8K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Diana Leitner — 2 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	30	1,770	$690	$1.3M
J2777	16	30	12,060	$30	$575.7K
J2778	19	20	860	$180	$297.6K
67028	14	40	1,170	$90	$111.4K
J7999	2	10	170	$40	$27K
99214	1,171	4,310	120	$70	$16.4K
92235	24	30	60	$90	$12.3K
99213	31	4,330	90	$50	$8.7K
92012	224	240	70	$60	$8.6K
67228	6	10	20	$250	$6.2K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Diana Leitner, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Grene Vision Group LLC	KS	Ophthalmology Physician	$0	$6.3M
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Diana Leitner, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Craig Resources LLC	KS	Home Health Agency	$0	$97.3M
Paradigm Services Inc	KS	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$42.4M
Wesley Medical Center LLC	KS	General Acute Care Hospital	$0	$30.2M
Gracemed Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$18.3M
Healthcore Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$15.3M
Diversified Family Services LLC	KS	Home Health Agency	$0	$13.9M
Alpha Service	KS	Developmentally Disabled Services Day Training Agency	$0	$12.1M
Carepoint Emergency Medicine Kansas LLC	KS	Emergency Medicine Physician	$0	$11.8M
Hunter Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$10.4M
Ascension Via Christi Hospitals Wichita Inc.	KS	General Acute Care Hospital	$0	$8.9M

Diana Leitner — Billing Profile & Reimbursement Data

Sign up for Diana Leitner — Billing Profile & Reimbursement Data policy alerts

Diana Leitner — Billing Profile & Reimbursement Data

Sign up for Diana Leitner — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References